Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

How does the brain change in chronic migraine? Developing disease biomarkers
Patricia Pozo‐Rosich, Gianluca Coppola, Julio Pascual, et al.
Cephalalgia (2020) Vol. 41, Iss. 5, pp. 613-630
Closed Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Navigating the Neurobiology of Migraine: From Pathways to Potential Therapies
Masaru Tanaka, Bernadett Tuka, László Vécsei
Cells (2024) Vol. 13, Iss. 13, pp. 1098-1098
Open Access | Times Cited: 13
Serum Alpha and Beta‐CGRP Levels in Chronic Migraine Patients Before and After Monoclonal Antibodies Against CGRP or its Receptor
Gabriel Gárate, Vicente González‐Quintanilla, Andrea González, et al.
Annals of Neurology (2023) Vol. 94, Iss. 2, pp. 285-294
Open Access | Times Cited: 22
CGRP and Migraine: What Have We Learned From Measuring CGRP in Migraine Patients So Far?
Katharina Kamm
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 28
Epigenetic Connection of the Calcitonin Gene-Related Peptide and Its Potential in Migraine
Michał Fila, Anna Sobczuk, Elżbieta Pawłowska, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 6151-6151
Open Access | Times Cited: 26
Serum alpha-CGRP levels are increased in COVID-19 patients with headache indicating an activation of the trigeminal system
Gabriel Gárate, María Toriello, Vicente González‐Quintanilla, et al.
BMC Neurology (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 14
DNA Damage and Repair in Migraine: Oxidative Stress and Beyond
Michał Fila, Aleksandra Jabłkowska, Elżbieta Pawłowska, et al.
The Neuroscientist (2022) Vol. 29, Iss. 3, pp. 277-286
Closed Access | Times Cited: 22
Altered functional connectivity of the right caudate nucleus in chronic migraine: a resting-state fMRI study
Ziyu Yuan, Wei Wang, Xueyan Zhang, et al.
The Journal of Headache and Pain (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 21
Altered Neuromagnetic Activity in the Default Mode Network in Migraine and Its Subgroups (Episodic Migraine and Chronic Migraine)
Xiaofang Zhang, Fengyuan Xu, Di Wu, et al.
Journal of Integrative Neuroscience (2024) Vol. 23, Iss. 1, pp. 19-19
Open Access | Times Cited: 3
Insights from 25 years of onabotulinumtoxinA in migraine — mechanisms and management
Patricia Pozo‐Rosich, Alicia Alpuente, Stephen D. Silberstein, et al.
Nature Reviews Neurology (2024) Vol. 20, Iss. 9, pp. 555-568
Closed Access | Times Cited: 3
Real-World Lessons with Fremanezumab as the Third Available CGRP Monoclonal Antibody in a Third-Level Hospital: Focus on the Factors Predicting Response
Marcos Polanco-Fernandez, Gabriel Gárate, Julia Sánchez-Gudín, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1054-1054
Open Access
Cortical metabolic and structural differences in patients with chronic migraine. An exploratory 18FDG-PET and MRI study
Marta Torres‐Ferrús, Deborah Pareto, Victor J Gallardo, et al.
The Journal of Headache and Pain (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 18
Deep and unbiased proteomics, pathway enrichment analysis, and protein–protein interaction of biomarker signatures in migraine
Yohannes W. Woldeamanuel, Bharati M. Sanjanwala, Robert P. Cowan
Therapeutic Advances in Chronic Disease (2024) Vol. 15
Open Access | Times Cited: 2
Association of a Cyclical Migraine Phenotype With Disease Progression
Victor J Gallardo, Alicia Alpuente, Patricia Pozo‐Rosich
Neurology (2022) Vol. 99, Iss. 12
Closed Access | Times Cited: 10
Health-Related Quality of Life in Migraine: EQ-5D-5L-Based Study in Routine Clinical Practice
Izabela Domitrz, Dominik Golicki
Journal of Clinical Medicine (2022) Vol. 11, Iss. 23, pp. 6925-6925
Open Access | Times Cited: 8
Comment on “Plasma calcitonin gene‐related peptide and nerve growth factor as headache and pain biomarkers in recently deployed soldiers with and without a recent concussion”
Gabriel Gárate, Julio Pascual
Headache The Journal of Head and Face Pain (2024) Vol. 64, Iss. 1, pp. 119-120
Closed Access | Times Cited: 1
Differences in circulating alpha‐calcitonin gene–related peptide levels in inflammatory bowel disease and its relation to migraine comorbidity: A cross‐sectional study
Marta Pascual, Gabriel Gárate, Vicente González‐Quintanilla, et al.
Headache The Journal of Head and Face Pain (2024) Vol. 64, Iss. 7, pp. 849-858
Open Access | Times Cited: 1
Onabotulinum toxin A vs. incobotulinum toxin A for the treatment of chronic migraine: a retrospective review
Scott Lucchese, Bob Daripa, Shruthi Pulimamidi
Research Square (Research Square) (2023)
Open Access | Times Cited: 2
Onabotulinumtoxin A (ONA-BoNT/A) in the treatment of chronic migraine
Izabela Domitrz, Jarosław Sławek, Agnieszka Słowik, et al.
Neurologia i Neurochirurgia Polska (2021) Vol. 56, Iss. 1, pp. 39-47
Open Access | Times Cited: 5
A critical review of the neurovascular nature of migraine and the main mechanisms of action of prophylactic antimigraine medications
Bruno A. Marichal‐Cancino, Abimael González‐Hernández, Raquel Guerrero‐Alba, et al.
Expert Review of Neurotherapeutics (2021) Vol. 21, Iss. 9, pp. 1035-1050
Closed Access | Times Cited: 4
The Responses to CGRP in the Territory of the Posterior Cerebral Artery in Migraine
Darja Visočnik, Marjan Zaletel, Matija Zupan, et al.
BioMed Research International (2022) Vol. 2022, pp. 1-6
Open Access | Times Cited: 3
A Retrospective Comparison of Onabotulinum Toxin A and Incobotulinum Toxin A in Terms of Efficacy, Tolerability, Duration of Effect, and Pain on Injection Administration Site for the Treatment of Chronic Migraine
Scott Lucchese, Bob Daripa, Shruthi Pulimamidi
Cureus (2024)
Open Access
Cognitive reserve and well-being in migraine patients: a multidimensional approach to migraine assessment in an Italian tertiary headache center
G. Paparella, Chiara Abbatantuono, Livio Clemente, et al.
Confinia Cephalalgica (2024) Vol. 34, Iss. 1
Open Access
Decoding Visual Responses: Insights into Chronic Migraine and Medication Overuse Headache with Electrophysiological Analysis
Gianluca Coppola, Francesco Casillo, Gabriele Sebastianelli, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 20, pp. 6070-6070
Open Access
Increase in CGRP levels in a case of hemicrania continua normalizes after a successful response to galcanezumab
Gabriel Gárate, Sara Pérez‐Pereda, Vicente González‐Quintanilla, et al.
Neurological Sciences (2022) Vol. 43, Iss. 7, pp. 4581-4582
Closed Access | Times Cited: 2
The Responses to CGRP in The Teritory of the Posterior Cerebral Artery in Migraine
Darja Visočnik, Marjan Zaletel, Bojana Žvan, et al.
Research Square (Research Square) (2021)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top